We recently reported that TGF-β–deficient mice of various genetic backgrounds, including TGF-β signaling adaptor Sptbn1+/- mice and double-knockout Sptbn1+/-/Smad3+/- mice, develop multiple tumors, including HCC [20, 43]. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.